“The cardiac toxicity of PAMAM dendrimer drug delivery systems can be attenuated with the adjunct use of cardioprotective agents” (2025) Biomolecules and Biomedicine, 25(4), pp. 914–924. doi:10.17305/bb.2024.10735.